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Background: The Tei index is a Doppler-derived myocardial performance index. It is a measure of the combined
systolic and diastolic myocardial performance of both the left and right ventricles. The incidence of heart failure
(HF) is increasing globally, and its severity can be clinically assessed using the New York Heart Association (NYHA)
functional classification and more objectively using echocardiographic assessment of systolic and diastolic functions.
Thus, a measure of the combined systolic and diastolic myocardial performance could be a useful predictor of the
severity of the clinical status of patients with HF.
Results: Seventy-five newly presenting patients with HF of NYHA class II to IV and 60 normal controls were
consecutively recruited. Using conventional two-dimensional and Doppler echocardiography techniques, the left
ventricular parameters assessed were the isovolumic relaxation time (IVRT), isovolumic contraction time (IVCT),
ejection time (ET), ejection fraction (EF), and end-diastolic volume (EDV). The Tei index was determined using the
formula IVCT + IVRT/ET. The mean Tei index of patients was significantly higher than that of controls (0.884 ± 0.321
vs. 0.842 ± 0.14; p < 0.001). The Tei index ranged from 0.33 to 1.94 in patients and from 0.56 to 1.24 in controls. The
mean EF was lower in patients than in controls (50.47% ± 19.01% vs. 68.35% ± 7.75%; p = 0.001). The mean EDV was
higher in patients than in controls (171.39 ± 100.96 vs. 94.15 ± 28.54; p < 0.001). Comparison of the mean Tei indices
of patients with HF of NYHA classes II, III, and IV showed statistically significant differences among all three groups
(p < 0.001).
Conclusions: The Tei index seems to be a clinically relevant indicator of cardiac function. It is reflective of the
severity of HF as clinically assessed using the NYHA functional classification in patients with HF.
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Heart failure (HF) is one of the most common diseases
of the heart in adults and accounts for an increasing
number of hospital admissions in the developed world
[1]. In Africa, at least 7% to 10% of all hospital admis-
sions are a result of HF [2,3]. It has been demonstrated
that systolic and diastolic dysfunctions coexist in the
majority of patients with congestive HF [4-7]. Echocardi-
ography has become the noninvasive method of choice
for the assessment of either systolic or diastolic left
ventricular (LV) function [8], and echocardiographic* Correspondence: joogunmola@yahoo.com
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reproduction in any medium, provided the orfindings are known to influence management decisions
and outcomes [9].
The ideal test for HF would be a noninvasive, inte-
grated assessment of systolic and diastolic LV function
that does not artificially uncouple systolic from diastolic
function, is independent of ventricular loading condi-
tions, and is reproducible during serial follow-up. A new
Doppler-derived index combining systolic and diastolic
time intervals proposed by Tei et al. in 1995 [10,11] ful-
fills some of these criteria. The Tei index has proven to
be a reliable method for the evaluation of LV systolic
and diastolic performance, with clear advantages over
older established indices. It takes into account both sys-
tolic and diastolic function and is reportedly simple, re-
producible, and independent of heart rate [12-14], bloodtral Ltd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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be significantly affected by loading conditions [16]. The
index is not influenced by LV geometry; hence, it does
not change significantly with enlargement or remodeling
of the heart [14,17,18]. The Tei index is defined as the
sum of the isovolumic contraction time (IVCT) and isovo-
lumic relaxation time (IVRT) divided by the ejection time
(ET). It has already been clinically applied in patients with
various etiologies of HF [10,11,19]. It is useful in the diag-
nosis of mild to moderate HF [13] and can reasonably sep-
arate normal subjects from those with HF [13,19].
The aim of the present study was to assess the rela-
tionship between the Tei index and HF of different se-
verities clinically assessed using the New York Heart
Association (NYHA) functional classification in patients
with HF.Methods
Study population
Seventy-five consecutive patients who fulfilled the
Framingham criteria [20] for diagnosis of HF were
recruited for this study. For the control group, 60
apparently healthy volunteers (without HF) were also
consecutively recruited. The inclusion criteria were
adult Nigerians 18 years and older with symptomatic
HF who gave informed consent to participate in the
study. The following patients were excluded: those
younger than 18 years, those who did not partake in or
complete the investigative profiles for the purpose of
this study, those with poor echocardiographic windows
or poor-quality echocardiograms, those not in sinus
rhythm or on paced rhythm, those with a bundle
branch block or high-grade atrioventricular block, and
those with severe mitral regurgitation [21-23].Study location
This study was conducted at the Cardiac Care Unit,
Department of Medicine, Obafemi Awolowo University
Teaching Hospitals Complex, Ile-Ife, Osun State,
Nigeria.Study design
This was a case–control study.Ethical consideration
Approval was obtained from the ethics and research
committee of the hospital, and signed informed consent
was obtained from each patient who participated in the
study. The study protocol conformed to the ethical
guidelines of the 1975 Declaration of Helsinki as
reflected in a priori approval from the institution’s hu-
man research committee.Sample size estimation
The minimum sample size was calculated using a formula
for estimating proportions with populations of less than
10,000: nf = n/1 + n/N. The value nf is the desired sample
size when the population is less than 10,000; N is the esti-
mated population size (this was estimated as the average
of 150 new patients with HF seen annually in the cardiac
unit); n is obtained using the formula n = z2pq / d2, where
z is the standard normal deviate using a 95% confidence
level of 1.96; p is the proportion of the target population
estimated to have a particular characteristic (the preva-
lence of HF is 2.8%–16%21; therefore, the midpoint is
9.4%); q is obtained using the formula 1.0 – p; and d is the
degree of accuracy desired, set at 0.05.
Thus,
n ¼ 1:96ð Þ2  0:094 0:906 = 0:05ð Þ2 ¼ 130:87;
and
nf ¼ 130:87 = 1þ 130:87 = 150 ¼ 70:
Clinical assessment
The diagnosis of HF was made using the Framingham
criteria [20,24] for definitive HF. NYHA functional
classes were determined on admission. Anthropometric
measurements included height, weight, waist circumfer-
ence, and body mass index. Peripheral arterial pulses
were assessed and blood pressures were measured on
admission [25,26].
Imaging procedures
For each patient, a chest radiograph (posteroanterior
view) was obtained at the radiology department to assess
the cardiac silhouette, aorta, and lung fields. A conven-
tional resting 12-lead electrocardiogram was obtained
with a Schiller AT-2 electrocardiographic machine.
Lead II was recorded for a long rhythm strip. The rec-
ommendations of the American Heart Association [27]
concerning standardization of leads and instrument
specifications were followed.
Echocardiographic examination
Two-dimensional (2-D), motion mode (M-mode), and
Doppler studies were performed with transthoracic
echocardiography using a Siemens Sonoline G60S
ultrasound imaging system with a P4-2 transducer.
Measurements were performed in accordance with the
recommendations of the American Society of Echocardi-
ography [28] with leading-edge-to-leading-edge record-
ings taken. Calculations were made using the internal
analysis software of the echocardiographic device. The
M-mode measurement of LV functions was performed
using the Teichholz formula. The 2-D views were used
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and as a reference for the selection of the M-mode
beam. The echocardiographic views utilized for the
study included the parasternal long-axis, short-axis, ap-
ical four-chamber, and apical five-chamber views. Pulsed
Doppler echocardiographic recordings of the mitral in-
flow were obtained from the apical four-chamber view
to assess LV filling dynamics. The Tei index was calcu-
lated from the ratio of time intervals expressed by the
formula a – b / b or IVCT + IVRT / ET [29]. Measure-
ments were taken from three consecutive beats and av-
eraged. The parameters for the formula were determined
by first locating the sample volume at the tips of the mi-
tral valve leaflets in the apical four-chamber view, which
enabled the measurement of ‘a’ (the time interval be-
tween the end and the start of transmitral flow). The
sample volume was then located in the LV outflow tract,
just below the aortic valve (apical five-chamber view) for
the measurement of ‘b’ (LV ejection time). The interval
‘a’ included the IVCT, ET, and IVRT.
Data analysis
The data were analyzed with a statistical computer soft-
ware package (SPSS version 16.0). Continuous variables
are expressed as mean ± standard deviation, and categor-
ical variables are expressed as percentages. Student’s
t-test was used to determine the difference between two
means. A p-value of ≤0.05 was considered statistically
significant.
Results
The sample frame comprised age- and gender-matched
patient and control groups (p = 0.62 and p = 0.55 for age
and gender, respectively), as shown in Table 1. The pa-
tient group comprised 42 (56.0%) male and 33 (44.0%)
female patients, while the control group comprised 38
(63.3%) male and 22 (36.7%) female subjects. The meanTable 1 Demographic parameters, mean ejection fraction,
and Tei index of patients and matched controls
Variables Patients (n = 75)
n (%)




18–44 9 (12.0) 6 (10) 0.62
45–64 25 (33.6) 21 (34.6)
≥65 41 (54.4) 33 (55.4)
Gender
Male 42 (56.0) 38 (63.3) 0.55
Female 33 (44.0) 22 (36.7)
Age (years)1 56 ± 18.33 57 ± 18.46 0.0753
Ejection fraction1 50.47 ± 19.01 68.37 ± 7.79 0.001
Tei index1 0.88 ± 32 0.36 ± 0.07 <0.001
1Mean ± standard deviation.ages of the patients and controls were 56 ± 18.33 (range,
22–88) and 57 ± 18.46 (range, 23–88) years, respectively
(p = 0.753). There was no statistically significant differ-
ence in age between the two groups (p = 0.069). The
EF was lower in patients with HF than in controls
(50.47% ± 19.01% vs. 68.37% ± 7.79%), and the difference
was statistically significant (p = 0.001). The Tei index
was easily obtained in all study subjects. The index was
significantly higher (p < 0.001) in patients with HF than
in control subjects (Table 1). The Tei index ranged from
0.33 to 1.94 in patients and from 0.56 to 1.24 in controls.
Patients with HF received combination therapy compris-
ing diuretics, ACE inhibitors, and aspirin or warfarin.
The etiology of HF in the study population is shown in
Table 2; the majority of HF was due to systemic hyper-
tension (68.0%). As also shown in Table 2, patients with
preserved systolic function had a lower Tei index than
did patients with reduced systolic function, and the dif-
ference was statistically significant (p = 0.003). As shown
in Table 3, there were significant differences in the mean
EF among the NYHA classes (p < 0.001). The mean EF
diminished from NYHA classes II to IV. In addition,
significant differences were present in the mean end-
diastolic volumes among NYHA classes II, III, and IV
(see Table 3). The mean end-diastolic volume was higher
in NYHA classes II to IV (p < 0.001). A total of 41% of
patients with HF recruited for this study presented in
NYHA class IV, and the others presented in NYHA clas-
ses III (30.6%) and II (28%). Comparison of the mean
Tei indices in NYHA classes II, III, and IV by means of
one-way analysis of variance showed statistically signifi-
cant differences among all three groups (p < 0.001).
According to Tukey’s post hoc test, the group compari-
sons that showed statistically significant differences were
those between NYHA classes II and IV (p < 0.001) and
III and IV (p < 0.001); no statistically significant differ-
ences were observed between II and III (p = 0.487). As
shown in Table 4, the EF and fractional shorteningTable 2 Etiology and ejection fraction of patients with
heart failure
Variables Patients (n = 75)
Etiology n (%)
Systemic hypertension 51 (68.0)
Dilated cardiomyopathy 10 (13.3)
Rheumatic heart disease 9 (12.0)
Congenital heart disease 2 (2.7)
Endomyocardial fibrosis 2 (2.7)
Acute myocardial infarction 1 (1.3)
Mean EF versus TI of patients (t = 3.03, p = 0.003)
EF≤ 45% (n = 32) 0.970 ± 0.34
EF > 45% (n = 43) 0.799 ± 0.27
EF, ejection fraction; TI, Tei index.
Table 3 Left ventricular function assessment across NYHA classes
Variables NYHA II NYHA III NYHA IV p value
Mean ejection fraction1 65.48 ± 16.38 53.69 ± 15.59 37.92 ± 14.35 <0.001
Mean end-diastolic volume1 91.50 ± 62.77 160.33 ± 76.42 233.73 ± 98.27 <0.001
Mean Tei index1 0.59 ± 0.14 0.79 ± 0.12 1.15 ± 0.30 <0.001
1Mean ± standard deviation; NYHA, New York Heart Association.
Table 4 Correlation of conventional echocardiographic
hemodynamic indices with the derived Tei index in the
study population





Mitral E/A ratio 0.238 0.022
DT 0.220 0.032
EF, ejection fraction; FS, fractional shortening; LVDD, left ventricular diastolic
dimension; LVSD, left ventricular systolic dimension; LVEDV, left ventricular
end-diastolic volume; DT, deceleration time.
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other hemodynamic parameters showed positive correla-
tions with the Tei index.
Discussion
The Tei index has been proven to be a reliable method
for the evaluation of LV systolic and diastolic perform-
ance, with clear advantages over older established indi-
ces and prognostic value in many kinds of heart disease
[10,13,14,18,30]. Our study revealed a relationship be-
tween clinically assessed HF severity and the Tei index.
This relationship in a black African population between a
bedside clinical marker of severity (NYHA classification)
and the Tei index further confirmed the usefulness of the
Tei index in assessing hemodynamic functions of patients
with HF. The Tei index in patients with HF was higher
and had a wider range than that in normal controls. This
higher Tei index in patients than in healthy individuals
was due to prolongation of the isovolumic time intervals
and a shortening of the ET. Similar findings were reported
by Bruch et al. [13] and Dujardin et al. [31].
Moreover, the mean Tei index was higher with in-
creased HF severity, and there were statistically signifi-
cant differences among all three groups (NYHA II, III,
and IV). This finding is in agreement with several others,
including the findings obtained by Tei et al. [10]. Their
study included patients with HF of NYHA class II to IV
with EFs of 30% to 50%, and a statistically significant
difference in the mean Tei index was present among the
NYHA functional groups. In addition, Ohno et al. [32]
showed that patients with advanced NYHA classifica-
tions or patients with restrictive LV filling patterns
(which reflect higher pulmonary wedge pressure) and
advanced congestive HF also exhibited an increased
myocardial performance index (Tei index).
Our study also revealed the trend of presentation of
patients with HF in our environment (41% of these pa-
tients were in NYHA class IV). In most such patients,
the HF is structurally advanced with an altered LV geo-
metric pattern, and the ellipsoid shape of the heart tends
to become spherical, leading to limitations in the use of
most of the traditional parameters for assessing systolic
and diastolic functions. This further buttresses the rele-
vance of the Tei index. The present study also demon-
strated the usefulness of the Tei index in HF of causes
other than hypertensive HF, as seen in a study of black
patients in Africa [33]. The dilated cardiomyopathiesfound in this study were diagnosed based on clinical and
classic echocardiographic findings. None were found to
have resulted from ischemia, alcohol, or any specific
cause within our limited resources. Another important
finding in this study was the significant correlation be-
tween the Tei index and other conventional indices of
systolic and diastolic functions.
Furthermore, in agreement with previous studies such
as that by Bruch et al. and Ambakederemo et al. [13,19],
the Tei index in controls was helpful in differentiating
between normal controls and patients with mild to mod-
erate HF (NYHA II and III functional classification). It
was also useful in differentiating patients with severe HF
(NYHA IV) from normal controls. More studies of
African individuals are needed to determine the cut-off
Tei index in normal subjects that would clearly separate
them from patients with HF.
The herein-described myocardial performance index
(Tei index), which combines systolic and diastolic time
intervals as an expression of global myocardial perform-
ance, correlates with cardiac function and seems to be a
useful complimentary marker in the assessment of LV
function. This combined measurement of ventricular
chamber performance may be more reflective of overall
cardiac dysfunction than systolic or diastolic measures
alone. In our environment, where people present in the
late stage of severe clinical HF, the Tei index may be
more effective because it is not based on a geometric
model or on volume measurement. A study of healthy
adults and patients with congestive HF reported by Cor-
reale et al. [34] investigated the clinical agreement be-
tween the Tei index measured conventionally and that
measured by pulsed-wave tissue Doppler of the mitral
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curacy for cardiac HF; however, this report addressed
the use of a higher myocardial performance index cut-
off point for the best diagnostic accuracy when using the
new pulsed-wave tissue Doppler index method [35].
This study has some limitations. First, the small sam-
ple size did not allow for adequate stratification for the
observation of the presence or absence of statistical sig-
nificance. Second, the effects of loading conditions and
arrhythmias on this index remain to be elucidated.
Finally, pseudonormalization of the index value was
present in this study.
Conclusions
In conclusion, this study indicates that the Tei index is a
useful myocardial performance index that has a promis-
ing role in determining overall cardiac dysfunction. It is
a reliable indicator of clinically assessed severe HF using
the NYHA functional classification.
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